Skip to main content
Log in

Incidence and characteristic of deep venous thrombosis in hospitalized chronic heart failure patients

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Background

This study was conducted to investigate the incidence of deep venous thrombosis (DVT), outcomes and its characteristics in patients with chronic heart failure (CHF) in a retrospective setting.

Outcomes

Patients died of cardiac shock or acute exacerbation of heart failure (HF), admitted to intensive care unit (ICU) due to acute exacerbation of HF, patients decided to withdraw treatment and return home due to acute exacerbation of HF.

Methods

From January 2015 to June 2022, we admitted 359 patients diagnosed with CHF, and lower limb ultrasonography was performed for the examination of DVT after admission. The incidence of DVT was recorded and patients with known risk factors of VTE were identified and excluded after incidence of DVT was calculated. Patients’ clinical data were then collected.

Results

The occurrence of DVT was 10.0% (36/359), as calf intramuscular vein thrombosis was the main constitution (n  =  28, 75%). DVT patients with other factors (carcinoma, surgery, stroke, previous history of DVT) constituted a considerable part (33.3%, 12/36). Age, history of Diabetes Mellitus (DM), levels of DDi (D-Dimer), levels of alanine transferase (ALT) and left ventricular end-diastolic diameter (LVEDd) were independent predictors or risk factors of DVT in CHF patients, while chronic kidney disease (CKD) stage 1–4, white blood cell (WBC) and direct oral anticoagulant (DOAC) were protective factors. Incidence of DVT was correlated with a poor outcome of CHF patients (Pearson Chi-Square test, Value 19.612, P  <  0.001).

Conclusions

In this retrospective study, incidence of DVT was found to be relatively high among hospitalized CHF patients, while patients with DVT was associated with a poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Samama MM (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160(22):3415–3420

    Article  CAS  PubMed  Google Scholar 

  2. Ng TMH, Tsai F, Khatri N, Barakat MN, Elkayam U (2010) Venous thromboembolism in hospitalized patients with heart failure. Circ Heart Fail 3:165–173

    Article  PubMed  Google Scholar 

  3. Alikhan R, Spyropoulos AC (2008) Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease. Am J Med 121:935–942

    Article  PubMed  Google Scholar 

  4. Jafri SM (1997) Hypercoagulability in heart failure. Semin Thromb Hemost 23:543–545

    Article  CAS  PubMed  Google Scholar 

  5. Piazza G, Seddighzadeh A, Goldhaber SZ (2008) Heart failure in patients with deep vein thrombosis. Am J Cardiol 101:1056–1059

    Article  PubMed  Google Scholar 

  6. Alikhan R, Cohen A, Combe S, Samama M, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson C, Turpie A (2003) Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 14:341–346

    Article  CAS  PubMed  Google Scholar 

  7. Fanola CL, Norby FL, Shah AM, Chang PP, Lutsey PL, Rosamond WD, Cushman M, Folsom AR (2020) Incident heart failure and long-term risk for venous thromboembolism. J Am Coll Cardiol 75:148–158

    Article  PubMed  PubMed Central  Google Scholar 

  8. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ (1997) Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 29:1074–1080

    Article  CAS  PubMed  Google Scholar 

  9. Smilowitz NR, Zhao Q, Wang L, Shrestha S, Baser O, Berger JS (2019) Risk of venous thromboembolism after new onset heart failure. Sci Rep 9:17415

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  10. Melgaard L, Nielsen PB, Overvad TF, Skjøth F, Lip GYH, Larsen TB (2019) Sex differences in risk of incident venous thromboembolism in heart failure patients. Clin Res Cardiol 108:101–109

    Article  CAS  PubMed  Google Scholar 

  11. Beemath A, Stein PD, Skaf E, Al Sibae MR, Alesh I (2006) Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol 98:793–795

    Article  PubMed  Google Scholar 

  12. Ota S, Yamada N, Tsuji A, Ishikura K, Nakamura M, Ito M (2009) Incidence and clinical predictors of deep vein thrombosis in patients hospitalized with heart failure in Japan. Circ J 73:1513–1517

    Article  PubMed  Google Scholar 

  13. Darze ES, Latado AL, Guimaraes AG, Guedes RA, Santos AB, de Moura SS, Passos LC (2005) Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit. Chest 128:2576–2580

    Article  PubMed  Google Scholar 

  14. Tagalakis V, Patenaude V, Kahn SR, Suissa S (2013) Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort. Am J Med 126(9):832.e13–21

    Article  PubMed  Google Scholar 

  15. White R, Zhou H, Murin S, Harvey D (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93:298–305

    Article  CAS  PubMed  Google Scholar 

  16. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland J, Coats A, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam C, Lyon AR, McMurray J, Mebazaa A, Mindham R, Muneretto C, Francesco PM, Price S, Rosano G, Ruschitzka F, Kathrine SA (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726

    Article  CAS  PubMed  Google Scholar 

  17. Duncan DP, Taddonio M, Chang EY, Huang BK (2019) Characterization of intramuscular calf vein thrombosis on routine knee MRI. Skeletal Radiol 48:1573–1580

    Article  PubMed  Google Scholar 

  18. Rose S, Zwiebel W, Miller F (1994) Distribution of acute lower extremity deep venous thrombosis in symptomatic and asymptomatic patients. J Ultrasound Med 13:243–250

    Article  CAS  PubMed  Google Scholar 

  19. Tebbe U, Schellong SM, Haas S, Gerlach HE, Abletshauser C, Sieder C, Bramlage P, Riess H (2011) Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY study. Am Heart J 161:322–328

    Article  CAS  PubMed  Google Scholar 

  20. Cohen A, Davidson B, Gallus A, Lassen M, Prins M, Tomkowski W, Turpie A, Egberts J, Lensing A (2006) Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 332:325–329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ (2000) Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 160:809

    Article  CAS  PubMed  Google Scholar 

  22. Heit JA, Spencer FA, White RH (2016) The epidemiology of venous thromboembolism. J Thromb Thrombolysis 41:3–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Howell MD, Geraci JM, Knowlton AA (2001) Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. J Clin Epidemiol 54:810–816

    Article  CAS  PubMed  Google Scholar 

  24. Matsuo H, Matsumura M, Nakajima Y, Ogawa T, Tazaki J, Doi T, Yamada N, Koide T, Mo M, Suzuki T, Sarai N, Nakajima H (2014) Frequency of deep vein thrombosis among hospitalized non-surgical Japanese patients with congestive heart failure. J Cardiol 64: 430–4.

  25. Di Nisio M, van Es N, Büller HR (2016) Deep vein thrombosis and pulmonary embolism. Lancet 388:3060–3073

    Article  PubMed  Google Scholar 

  26. Clagett G, Anderson F, Geerts W, Heit J, Knudson M, Lieberman J, Merli G, Wheeler H (1998) Prevention of venous thromboembolism. Chest 114:531S-560S

    Article  CAS  PubMed  Google Scholar 

  27. Engbers MJ, van Hylckama VA, Rosendaal FR (2010) Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 8:2105–2112

    Article  CAS  PubMed  Google Scholar 

  28. Zhu R, Hu Y, Tang L (2017) Reduced cardiac function and risk of venous thromboembolism in Asian countries. Thromb J 15:12

    Article  PubMed  PubMed Central  Google Scholar 

  29. Klein L, O’Connell JB (2007) Thromboembolic risk in the patient with heart failure. Curr Treat Options Cardiovasc Med 9:310–317

    Article  PubMed  Google Scholar 

  30. Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E, Oakley C, Cleland J (1994) Relationship between hemostatic abnormalities and neuroendocrine activity in heart-failure. Am Heart J 127:607–12

    Article  CAS  PubMed  Google Scholar 

  31. Jug B, Vene N, Salobir BG, Šebeštjen M, Šabovic M, Keber I (2009) Procoagulant state in heart failure with preserved left ventricular ejection fraction. Int Heart J 50:591–600

    Article  CAS  PubMed  Google Scholar 

  32. Buckheit D, Lefemine A, Sobieraj DM, Hobbs L (2021) Venous thromboembolism prophylaxis in underweight hospitalized patients. Clin Appl Thromb Hemost 27:10760296211018752

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Masotti L, Godoy DA, Napoli MD, Rabinstein AA, Paciaroni M, Ageno W (2012) Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage. Clin Appl Thromb Hemost 18:393–402

    Article  CAS  PubMed  Google Scholar 

  34. Jain H, Singh G, Kaul V, Gambhir HS (2022) Management dilemmas in restarting anticoagulation after gastrointestinal bleeding. Proc (Bayl Univ Med Cent) 35:322–327

    PubMed  Google Scholar 

  35. Leonardi M, McGory M, Ko C (2006) The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis—a systematic review of 33 randomized controlled trials. Arch Surg 141:790–797

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank our co-mentor Hong who have always inspired us to pursue knowledge of cardiology.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chuang-Xiong Hong.

Ethics declarations

Conflict of interest

There is no potential competing interest exists.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, JL., Xiao, W.K., Zhang, C.Q. et al. Incidence and characteristic of deep venous thrombosis in hospitalized chronic heart failure patients. Heart Vessels (2024). https://doi.org/10.1007/s00380-024-02377-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00380-024-02377-7

Keywords

Navigation